A collection of data from clinical cases in humans and studies in mouse models highlight a rather complex role of the IFN-I system in obesity, mainly pointing to defects of IFN production/signaling as one possible explanation of the well-described enhanced susceptibility of obese subjects to infectious diseases and in the progression to obesity itself. The gene discussed is IFNA1; the disease is obesity disorder.